Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Adipose-Derived Mesenchymal Stem Cell Exosome miR-146a-5p Attenuates TGF-β2-Induced Transformation of Human Tenon's Capsule Fibroblasts by Targeting SMAD4.

Bao H., Tang T., Li M., Li Y., Song D., Ma Y.

Animal Study on Chronic Wound, Scar, published in Invest Ophthalmol Vis Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Invest Ophthalmol Vis Sci (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42578587
DOI
10.1167/iovs.67.10.26

Abstract (original English)

Purpose Conjunctival fibrosis is the major impediment to the success of glaucoma filtration surgery. Exosomes secreted by human adipose-derived mesenchymal stem cells (hADSCs) could alleviate a variety of tissue fibrosis. However, the molecular mechanism of hADSCs-derived exosomes (hADSC-exos) in postoperative glaucoma follicle scarring is still unclear. Methods The hADSC-exos were identified by a transmission electron microscope and nanoparticle tracking analysis. The hADSC-exos were traced in vitro by PKH67 staining, and uptake of exosomes by human Tenon's capsule fibroblast (HTF) cells was detected by the confocal method. After co-culturing hADSC-exos and transforming growth factor beta-2 (TGF-β2), HTF proliferation and migration were detected using Cell Counting Kit-8 and wound healing assay. Protein levels were examined using Western blot. The binding between miR-146a-5p and SMAD4 was predicted and verified using dual-luciferase reporter and RNA immunoprecipitation assay. Gain/loss-of-function studies using microRNA (miRNA)-modified exosomes and direct mimic transfection were performed. Anti-fibrotic efficacy was examined by a trabeculectomy model using New Zealand white rabbits in vivo. Results The hADSC-exos could be internalized by HTFs. The miRNA-146a-5p is the most significantly upregulated in HTFs co-stimulated by TGF-β2 and hADSC-exos. After the screening, miR-146a-

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Tenon CapsuleHumansSmad4 ProteinExosomesTransforming Growth Factor beta2MicroRNAsMesenchymal Stem CellsAnimalsRabbitsFibroblasts

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research